These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34230061)

  • 1. Within-Hospital Concordance of Opioid Exposure Diagnosis Coding in Mothers and Newborns.
    Clark RRS; French R; Lorch S; O'Rourke K; Rosenbaum KEF; Lake ET
    Hosp Pediatr; 2021 Aug; 11(8):825-833. PubMed ID: 34230061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal Opioid Use Disorder and Neonatal Abstinence Syndrome Among Rural US Residents, 2007-2014.
    Kozhimannil KB; Chantarat T; Ecklund AM; Henning-Smith C; Jones C
    J Rural Health; 2019 Jan; 35(1):122-132. PubMed ID: 30370563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital Care of Opioid-Exposed Newborns: Clinical and Psychosocial Challenges.
    Goyal NK; McAllister J
    J Hosp Med; 2020 Oct; 15(10):613-618. PubMed ID: 32118559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
    Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
    Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Administrative Data for Identifying Maternal Opioid Use at Delivery in Florida.
    Elmore AL; Salemi JL; Kirby RS; Sappenfield WM; Lowry J; Dixon A; Lake-Burger H; Tanner JP
    Matern Child Health J; 2023 Dec; 27(Suppl 1):44-51. PubMed ID: 37199857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
    Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
    Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses: Analysis of ICD-10-CM Transition, 2013-2017.
    Ko JY; Hirai AH; Owens PL; Stocks C; Patrick SW
    Hosp Pediatr; 2021 Aug; 11(8):902-908. PubMed ID: 34321311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013-2016.
    Clemans-Cope L; Lynch V; Howell E; Hill I; Holla N; Morgan J; Johnson P; Cross-Barnet C; Thompson JA
    Drug Alcohol Depend; 2019 Feb; 195():156-163. PubMed ID: 30677745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in maternal opioid use disorder and neonatal abstinence syndrome in Maine, 2016-2022.
    Dudley J; Gabrielson SMB; O'Connor AB; Ahrens KA
    J Perinatol; 2024 Aug; 44(8):1104-1110. PubMed ID: 38267636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015.
    Dave CV; Goodin A; Zhu Y; Winterstein A; Wang X; Alrwisan A; Hartzema A
    Pharmacotherapy; 2019 Oct; 39(10):1005-1011. PubMed ID: 31361913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographics, Birth Parameters, and Social Determinants of Health Among Opioid-Exposed Mother-Infant Dyads Affected by Neonatal Abstinence Syndrome in Pennsylvania, 2018-2019.
    Decker CM; Mahar M; Howells CL; Ma ZQ; Goetz CT; Watkins SM
    Matern Child Health J; 2023 Dec; 27(Suppl 1):34-43. PubMed ID: 37243807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case-control study comparing rates and diagnoses of hospital readmission in infants affected by neonatal abstinence syndrome.
    Salt E; Wiggins A; Pick A; Bada H; Howard C; Currie M; Rayens MK
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2162820. PubMed ID: 36597833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.
    Patrick SW; Schumacher RE; Benneyworth BD; Krans EE; McAllister JM; Davis MM
    JAMA; 2012 May; 307(18):1934-40. PubMed ID: 22546608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse neonatal outcomes associated with maternal severe mental health diagnoses and opioid use.
    Ma J; Sahasranaman V; Kirby RS; Boaz T
    J Perinatol; 2020 Oct; 40(10):1497-1505. PubMed ID: 32753708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery.
    Nielsen T; Bernson D; Terplan M; Wakeman SE; Yule AM; Mehta PK; Bharel M; Diop H; Taveras EM; Wilens TE; Schiff DM
    Addiction; 2020 Feb; 115(2):291-301. PubMed ID: 31692133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality.
    Grossarth S; Osmundson SS; Wiese AD; Phillips SE; Pham A; Leech AA; Patrick SW; Spieker AJ; Grijalva CG; Adgent MA
    JAMA Pediatr; 2023 Jul; 177(7):675-683. PubMed ID: 37155175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of pharmaceutical drugs of dependence to the incidence of neonatal abstinence syndrome in Western Australia between 2003 and 2018.
    Kelty EA; Cumming CN; Preen DB
    Pharmacotherapy; 2022 May; 42(5):405-410. PubMed ID: 35342965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Substance-Exposed Newborns and Neonatal Abstinence Syndrome Using ICD-10-CM - 15 Hospitals, Massachusetts, 2017.
    Goyal S; Saunders KC; Moore CS; Fillo KT; Ko JY; Manning SE; Shapiro-Mendoza C; Gupta M; Romero L; Coy KC; McDow KB; Keaton AA; Sinatra J; Jones K; Alpren C; Barfield WD; Diop H
    MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(29):951-955. PubMed ID: 32701936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal opioid exposure, neonatal abstinence syndrome, and infant healthcare utilization: A retrospective cohort analysis.
    Ko JY; Yoon J; Tong VT; Haight SC; Patel R; Rockhill KM; Luck J; Shapiro-Mendoza C
    Drug Alcohol Depend; 2021 Jun; 223():108704. PubMed ID: 33894458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a Nurse-Led Program for Rural Pregnant Women With Opioid Use Disorder to Improve Maternal-Neonatal Outcomes.
    Paterno MT; Jablonski L; Klepacki A; Friedmann PD
    J Obstet Gynecol Neonatal Nurs; 2019 Sep; 48(5):495-506. PubMed ID: 31374181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.